Gel4Med, Inc.

  Exciting Announcement: Join us at the SAWC Fall Conference 2024! 🎉 We're thrilled to announce that our team at Gel4Med, Inc. will be attending the Symposium on Advanced Wound Care (SAWC) Fall Conference, from October 2-5, in Las Vegas, NV. This prestigious event brings together the brightest minds in wound care and cutting-edge advancements in surgical treatment solutions. Multiple Presentations: 🤩 We’re proud to be presenting our latest clinical case series on the treatment of difficult wounds, which highlights the exciting clinical outcomes of our flagship product, G4Derm Plus. Visit our posters to discover how our technology is making strides in the management of challenging wounds, including venous leg ulcers, diabetic foot ulcers, and surgical wounds. G4Derm Plus is now being evaluated in over 16 clinical sites in the United States, garnering support from top academic research institutions such as Massachusetts General Hospital, UPenn, UTSW, and Robert Wood Johnson facilities, among others. We invite you to try G4Derm Plus and join us in our Product Evaluation Program by connecting with our clinical operations team at info@gelformed.com. Partnership opportunities: 🤝 Connect with us during the SAWC conference to learn more about how Gel4Med is shaping the future of wound care and beyond. We are always open to engaging in meaningful discussions and exploring partnership opportunities to broaden the reach of our products. If you're interested in connecting, please get in touch with our Business Development Manager, Rebecca Salamone, MS by emailing bd@gelformed.com and company CEO, Manav Mehta. See you there! ✈️ #SAWCFall2024 #WoundCare #DifferenceMakers #Partnerships #Innovation #Healthcare #Biomaterials 

Read our most recent press release on our feature in Podiatry Today as a Top 10 Innovation in Wound Care and learn how Gel4Med is shaping the future of wound care with their novel biomaterials approach.    #PodiatryToday #MedicalDevice #Innovation #HarvardInnovationLabs #UmassM2D2 #WoundCare #TissueRegeneration #SurgicalWoundClosure #TherapeuticMaterials #Biomaterials #Surgery #HealthcareInnovation #MedTech #Biotech #TissueEngineering #RegenerativeMedicine #PatientCare #Gel4Med

🎉 Exciting News!🎉 Gel4Med is thrilled to announce that Podiatry Today has recognized Gel4Med’s innovative product, G4Derm Plus, as one of the Top 10 Innovations in Podiatry. This achievement reflects the relentless dedication of the Gel4Med team to design and develop transformative technology focused on advancing biomaterials and patient outcomes. Our deepest gratitude extends to Dr. Stephanie Wu, DPM for her support in recognition of our technology as an innovative solution in wound care, along with our clinical collaborators. Their steadfast belief and support in our team and technology continue to guide us through challenges and push the boundaries of innovation. We’re just getting started, and we invite you to be part of this exciting journey. Gel4Med invites those attending the Symposium on Advanced Wound Care (SAWC) Fall Conference in Las Vegas, October 2-5, 2024, to connect with the team to learn more about the Company’s portfolio and engineered biomaterials solutions.  Gel4Med isn’t just building products; we’re cultivating a community of innovators and change-makers. Whether you’re interested in partnerships, strategic/distribution opportunities, or investing, there’s a place for you here. If you’re interested in partnering with the Company, please get in touch with our team at info@gelformed.com  For more information on the recognition, we invite you to read about the Top 10 Innovations in Podiatry Today. Stay tuned for updates on the launch and availability of G4Derm and G4Derm Plus in 2024. #PodiatryToday #MedicalDevice #Innovation #HarvardInnovationLabs #UmassM2D2 #WoundCare #TissueRegeneration #SurgicalWoundClosure #TherapeuticMaterials #Biomaterials #Surgery #HealthcareInnovation #MedTech #Biotech #TissueEngineering #RegenerativeMedicine #PatientCare #Gel4Med

🎙 Exciting News! 🎉 Gel4Med is thrilled to announce that our Associate Director of Product Development, Ana Tellechea, PharmD, PhD will be delivering a podium presentation at the Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) 2024 Conference on May 16th at 10:30am! A few words from Dr. Tellechea, “I am honored to have the opportunity to share Gel4Med’s recent findings in the field of wound care at this esteemed event. My presentation will delve into the antimicrobial protection and superior wound healing outcomes of our innovative biomimetic matrix product, and I look forward to receiving high-quality feedback from researchers, clinicians, and industry representatives alike.”  The SAWC Spring | WHS Conference is renowned for bringing together thought leaders, practitioners, and researchers in wound care from around the globe, providing a platform for collaboration, learning, and advancing the field. We are eager to strengthen our active contribution to this vibrant community and engage in meaningful discussions that drive progress and improve patient outcomes. We look forward to connecting with colleagues, exchanging ideas, and exploring new opportunities for collaboration at the SAWC Spring | WHS 2024 conference. If you're attending the event, we would be delighted to meet you at Dr. Tellechea’s presentation or connect during the conference. Thank you to the organizers of the SAWC and WHS joint annual meeting for this incredible opportunity. We can't wait to see you all in Orlando! #SAWC #WHS #WoundHealing #WoundCare #ConferencePresentation #Networking #Innovation #HealthcareLeadership #Biomaterials #SmartMaterials

Unleashing our cell delivery platform for solving unmet clinical needs in Spinal Cord Injury! Onwards and Upwards 🎉

🎉 Great News from Gel4Med! 🎉 We are thrilled to announce a pivotal three-year research collaboration with Dr. Damien Pearse, Ph.D., Professor of Neurological Surgery at the University of Miami Miller School of Medicine, supported by a Department of Defense (DoD) grant. Rebecca Salamone, MS, our Manager of Business Development for North America, shares her excitement: "We are incredibly excited about the potential of our collaboration with Dr. Pearse and the University of Miami. This partnership allows us to push the boundaries of medical technology, exploring innovative approaches to treat spinal cord injuries that could fundamentally change patient care. We're eager to develop technologies that are not only groundbreaking but also make a direct impact." Our Mission: · Innovative Cell Therapy: Utilizing Gel4Med’s proprietary Smart Materials Platform™, we aim to revolutionize treatment for spinal cord injuries by delivering Schwann cells directly to the lesion sites. · Esteemed Partnership: Collaborating with the University of Miami/Miami Project to Cure Paralysis, renowned for its academic excellence and pioneering research in spinal cord injury. We are incredibly proud to join forces on this venture and are eager to share the impactful breakthroughs that will undoubtedly emerge from our joint efforts. 🌟 Here's to groundbreaking discoveries and innovations ahead! For more details, read the full story here: The Miami Project and Gel4Med, Inc., Collaborate to Study Novel Approach to Spinal Cord Injuries - InventUM. #Innovation #Biomaterials #Gel4Med #SyntheticBiology #ImpactfulResearch #AcademicAchievements #Collaboration #DepartmentOfDefense #Research #SpinalCordInjury

🎉 Great News from Gel4Med! 🎉 We are thrilled to announce a pivotal three-year research collaboration with Dr. Damien Pearse, Ph.D., Professor of Neurological Surgery at the University of Miami Miller School of Medicine, supported by a Department of Defense (DoD) grant. Rebecca Salamone, MS, our Manager of Business Development for North America, shares her excitement: "We are incredibly excited about the potential of our collaboration with Dr. Pearse and the University of Miami. This partnership allows us to push the boundaries of medical technology, exploring innovative approaches to treat spinal cord injuries that could fundamentally change patient care. We're eager to develop technologies that are not only groundbreaking but also make a direct impact." Our Mission: · Innovative Cell Therapy: Utilizing Gel4Med’s proprietary Smart Materials Platform™, we aim to revolutionize treatment for spinal cord injuries by delivering Schwann cells directly to the lesion sites. · Esteemed Partnership: Collaborating with the University of Miami/Miami Project to Cure Paralysis, renowned for its academic excellence and pioneering research in spinal cord injury. We are incredibly proud to join forces on this venture and are eager to share the impactful breakthroughs that will undoubtedly emerge from our joint efforts. 🌟 Here's to groundbreaking discoveries and innovations ahead! For more details, read the full story here: The Miami Project and Gel4Med, Inc., Collaborate to Study Novel Approach to Spinal Cord Injuries - InventUM. #Innovation #Biomaterials #Gel4Med #SyntheticBiology #ImpactfulResearch #AcademicAchievements #Collaboration #DepartmentOfDefense #Research #SpinalCordInjury